EA
DSCI

Emerald Acquisition’s Derma Sciences, Inc. Common Stock (DE) DSCI Stock Holding History

Emerald Acquisition’s Portfolio DSCI Stock Details DSCI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		$114K Sell
24,482
-26,972
-52% -$126K ﹤0.01% 2791
2016
Q2 		$202K Buy
+51,454
New +$192K ﹤0.01% 2727

Other funds holding DSCI

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Manulife (Manufacturers Life Insurance)
Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada $116B AUM 26.37% 1-Year Est. Return
DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return

Emerald Acquisition's DSCI Position: Q3 2016 in Review

Emerald Acquisition reduced its Derma Sciences, Inc. Common Stock (DE) (DSCI) stake by 52% in Q3 2016, selling an estimated $126K and leaving 24,482 shares worth $114K. The position accounts for ﹤0.01% of the portfolio, ranked #2791.

Emerald Acquisition first reported a position in DSCI in Q2 2016 and has held it in 2 quarters since. The position peaked at $202K in Q2 2016. 61 funds tracked by Wall St. Rank hold DSCI as of Q3 2016.

  • Emerald Acquisition held 24,482 shares of Derma Sciences, Inc. Common Stock (DE) worth $114K as of Q3 2016.
  • Emerald Acquisition sold 26,972 Derma Sciences, Inc. Common Stock (DE) shares in Q3 2016, an estimated $126K.
  • Derma Sciences, Inc. Common Stock (DE) made up ﹤0.01% of Emerald Acquisition's portfolio in Q3 2016, its #2791 holding.
  • Emerald Acquisition first reported a position in Derma Sciences, Inc. Common Stock (DE) in Q2 2016 and has held it in 2 quarters since.
  • Emerald Acquisition's Derma Sciences, Inc. Common Stock (DE) position peaked at $202K in Q2 2016.
  • 61 funds tracked by Wall St. Rank held Derma Sciences, Inc. Common Stock (DE) as of Q3 2016.

Based on Emerald Acquisition's 13F filing for Q3 2016, filed 9 Nov 2016.